Better educate patients, providers, and opinion leaders across the product lifecycle - from clinical trials to real world use.
As patients go through various stages of the treatment journey, their needs for support change. Now, with advanced analytics and machine learning, IQVIA can help you predict issues before they occur and to design and roll out programs that have a better chance of keeping patients engaged with treatment.
To be effective, strategies for supporting adherence must evolve as patients progress through their treatment journey.
IQVIA’s adherence solutions help you support patients throughout each of these stages. We use machine learning to detect when patients begin dropping therapy. And we interpret the data so you can drill down into details, and implement targeted programs that improve outcomes for specific patient profiles.
Systematic support can produce a meaningful improvement in patient adherence, and can spark a self-sustaining cycle of improvements for all stakeholders
IQVIA's adherence service are delivered by nurses who recognize the importance of delivering the whole range of support as part of a comprehensive adherence program.
In a survey by the New England Journal of Medicine, 59% of respondents said that increasing face-to-face time with patients was the best patient engagement strategy, followed by shared decision making initiatives, which were highlighted by 54 % of respondents.
Better educate patients, providers, and opinion leaders across the product lifecycle - from clinical trials to real world use.
Develop a full, multi-tactic communications strategy to reach and engage patients and other stakeholders.
Deploy sales representatives, clinical nurse educators, field reimbursement specialists virtually or in the field to communicate the benefits of your therapy.